0001179110-20-001872.txt : 20200219
0001179110-20-001872.hdr.sgml : 20200219
20200219172457
ACCESSION NUMBER: 0001179110-20-001872
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200214
FILED AS OF DATE: 20200219
DATE AS OF CHANGE: 20200219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beetham Thomas W.
CENTRAL INDEX KEY: 0001741382
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 20631283
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD.
STREET 2: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
edgar.xml
FORM 4 -
X0306
4
2020-02-14
0
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001741382
Beetham Thomas W.
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON
D0
HM11
BERMUDA
0
1
0
0
EVP & Chief Legal Officer
Class A Common Shares
2020-02-14
4
S
0
59
18.58
D
79530
D
The sale of Class A Common Shares reported in this From 4 was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on December 24, 2019.
/s/ Theresa Boni, Attorney-in-Fact For Thomas W. Beetham
2020-02-19